Summary Two hundred and eighty-eight primary breast tumours were examined for the presence or absence of oestrogen (RE,) 
positive and negative tumours when the axillary node status was taken into account.
Increased recognition of the importance of selective hormone binding in initiating steroid action in target tissues has led to the study of oestrogen and progesterone binding by human breast cancer. Though the receptor content of the primary tumour is reported to be independent of factors such as tumour site or size, age of patient or degree of axillary node involvement (Knight et al., 1977) (Sander, 1968; Korenman & Dukes, 1970; Johansson et al., 1970; Feherty et al., 1971; Wittliff et al., 1971; LeClercq et al., 1973; Terenius et al., 1974; Aspergren & Hakansson, 1974) . However, in some of these studies numbers were small and methods of REC analysis and morphological examination were inconsistent. More recent studies have shown that REC may be closely related to tumour grade Martin et al., 1979b; Rasmussen et al., 1981; Thoresen et al., 1981) , to the histological type and degree of lymphocytic infiltration of primary tumour (Rosen et al., 1975) and to the presence or absence of elastosis in the tumour stroma (Masters et al., 1976) . Similar links have been recognised between the progesterone receptor (RPc) and histological grade and elastosis (Martin et al., 1979b; Rolland et al., 1980) , but a relationship between RPC and other aspects of tumour morphology has not been reported.
Most investigators who have studied the relationship between REC and freedom from recurrence and survival, have suggested that an earlier recurrence and shorter survival may be expected in those patients who lack REC in their primary tumour, although data vary as to which patients obtain the greatest benefit (Knight et al., 1977; Bishop et al., 1979; Cooke et al., 1979; Allegra et al., 1979; Forrest et al., 1980; Westerberg et al., 1980; Croton et al., of this receptor as a prognostic factor in breast cancer remains uncertain. The objectives of this single centre study were twofold: to test the hypothesis that the presence or absence of RE, and RP, is a reflection of certain morphological features of the tumour, some of which are of prognostic significance in their own right and to investigate the role of REc and RPc as indicators of early recurrence.
Materials and methods
Oestrogen and progesterone receptor assay Samples of histologically proven primary tumours from women with breast cancer were studied.
Portions for oestrogen (RE,) and progesterone (RPj) receptor measurement were selected at the time of surgery by the pathologist who received tissue for frozen section. They were stored in liquid nitrogen until required for analysis, and then homogenised and centrifuged. The receptor content of the cytosol was measured by incubation with either tritiated oestradiol in the presence or absence of diethyl-stilboestrol as a competitor for specific oestrogen receptor sites, or tritiated R5020 and radio-inert R5020, a synthetic progestin, for specific progesterone receptor sites. Non-receptor bound [3H]-hormone was separated from hormone bound to receptors by adsorption on to Dextran-coated charcoal (DCC). The activity of the receptor-bound radio-labelled hormone remaining in the supernatant was measured in a scintillation counter and the data analysed according to Scatchard (1949) . Values > 5 fM mg 1 for REC and >15 fM mg-1 for RPC of cytosol protein were regarded as positive (Barnes et al., 1977; Skinner et al., 1980) . Negative results from tumours where the cytosol protein was <0.7 mg ml-were not accepted as valid and were excluded from the study.
Histology
The pathological features of 288 unselected primary malignant breast tumours were reviewed retrospectively by one pathologist who was unaware of the receptor status. His observations were based on the examination of routine paraffin wax embedded sections stained with haematoxylin and eosin and sections stained for elastic tissue with Miller's Victoria blue and Van Geison stain. The following pathological observations were made: the maximum diameter, the nature of the margin (circumscribed or stellate), and the histological type of the primary tumour. The grade of infiltrating duct tumours was assessed on a scale of 1 (welldifferentiated) to 3 (poorly-differentiated) taking into account tubular differentiation, nuclear pleomorphism and mitotic activity according to the method recommended by Scarff & Torloni (1968) which is essentially that of Bloom & Richardson (1957) . For studies of RFS time-based curves were computed by actuarial methods and compared by the log-rank test (Peto et al., 1977 (Figure 4 ).
There was no association between the degree of lymphocytic infiltration and the value of either receptor (REC, P = 0.9; RPc, P = 0.3).
In ter-relationiships of grale, lmipjhoc Itic inifiltraCltion andlCI elastosiS There was a highly significant association between the degree of lymphocytic infiltration and histological grade of infiltrating duct tumours (Table II) . High grade tumours contained the most marked lymphoid reaction (P<0.0001). Table III summarizes the inverse association between the degree of elastosis and histological grade, elastosis being most marked in grade I tumours (P=0.0001).
Receptor statuis aind nio(le nietastases
There was no association between the receptor status of the primary tumour and the number of axillary lymph nodes containing metastases (RE us.
nodes, P =0.3; RPC vs. nodes, P =0.7). The histological findings are summarized in Table IV . and 29 months after the last patient entered the study. At a median observation period of 24 months, a statistically significant increase in RFS was found for patients who possessed REC compared with those who lacked this receptor (P =0.02). This difference was no longer significant at a median period of observation of 34 months ( Figure 5 ). When the patients were divided into 4 groups according to the REc content of the tumour (REC negative, 5-30, 3 1-100, > 100 fM mg -I cytosol protein) there was no statistical relationship between RFS and the REC value at any time ( Figure  6 ). In 163 patients RPc was also measured. The presence of this receptor was not related to RFS (Figure 7 ). This was noted in both REc positive and REC negative tumours, although the number of patients who possessed RPC and lacked REC was very small.
The importance of the presence of metastases in the ipsilateral axillary nodes in determining the prognosis in breast cancer has been emphasised (Say & Donegan, 1974; Fisher et al., 1975) . This was confirmed in the present study. The overall recurrence rate was significantly higher in node + ve patients regardless of their receptor status (P <0.001). Three years after mastectomy 80% of patients without axillary node involvement remained free from recurrence compared with 56% of those who had 1-3 involved nodes and less than 30% of patients with 4 or more nodes containing tumour.
RFS was analysed in relation to receptor status and axillary node involvement (Figure 8 ). There was no statistically significant difference in the RFS between REC + ve and REC -ve tumours in patients without axillary metastases (P> 0;9) or in patients with extensive nodal disease (.4) (P=0.2).
In patients with 1-3 axillary nodes involved, RE, +ve tumours were associated with a longer RFS than REC -ve tumours at a median observation period of 24 months (P = 0.05), but not at 34 months (P = 0.07). There were no differences between the RFS of RPc + ve and RPc -ve tumours in any axillary node subgroup.
Discussion
Breast cancer varies in its responsiveness to hormones, and is the first disease in which estimation of tissue receptors at the time of initial surgery has been advocated as a method of identifying patients with the greatest risk of recurrence. The purpose of this study was to examine inter-relationships between steroid receptor activity and a variety of histological features, and to We have shown REC and RPC to be independent of certain factors known to influence the natural history of the disease, for example tumour size, and the nature of its margin and axillary metastases (Fisher et al., 1975 Antoniades & Spector (1979) . We also confirmed reports of a high incidence of REC in invasive lobular tumours (Rosen et al., 1975; Antoniades & Spector, 1979; Martin et al., 1979b; Rasmussen et al., 1981) . Other workers have failed to demonstrate any such association (Johansson et al., 1970; Feherty et al., 1971; Wittliff et al., 1971; LeClercq et al., 1973; Aspegren & Hakansson, 1974) , but in most series the majority of tumours were infiltrating duct carcinomas and, as in the present study, the number of uncommon histological types was too small to permit statistical evaluation. The finding that both invasive lobular and tubular carcinomas have a high incidence of REC supports the hypothesis that they are extreme variants of the same histological entity (Eusebi et al., 1979) .
Although in the past it was generally accepted that there was no association between the presence of REC and the histological features of infiltrating duct tumours (Johansson et al., 1970; Feherty et al., 1971; Rosen et al., 1975) , only Feherty used the W.H.O. recommended system of grading. More recently, using this method exclusively, ), Martin et al. (1979b , Rasmussen et al. (1981) and Thoresen et al. (1981) have shown a definite relationship between histological grade and REC.
Our data agree with the latter reports and in addition have confirmed the findings of Martin et al. (1979b) that the possession of RPC is also linked to histological grade. Terenius et al. (1974) was unable to show a relationship between the presence or absence of RE, and grade, but found that REC values were statistically higher in well-differentiated tumours. The method of grading was not specified. In the present study, as in that of Heusen et al. (1975) and Thoresen et al. (1981) , the mean value of the receptors was similar in all three grades, and thus the significance of the association between grade and presence or absence of receptor is difficult to interpret. Silvestrini et al. (1979) incidence of REC. This, and the frequency with which receptors are found in low grade tumours suggests that receptors are associated in some way with low rates of cellular replication.
Cellularity, when assessed both at the centre and the edge of the tumour to avoid sampling errors, was unrelated to the presence of REc and RP,. the mean value of the progesterone receptors was similar for all degrees of cellularity. These findings are identical with those of Masters et al. (1978) and similar, in part, to the results of Terenius et al. (1974) , Antoniades & Spector (1979) and Martin et al. (1979a) . Rosen et al. (1975) observed some association between cellularity and RE, value but did not consider it significant . Feherty et al. (1971) and Rasmussen et al. (1981) were unable to show this association. The failure to demonstrate such a link may be the result of unavoidable variation in methods used to assess cellularity (Antoniades & Spector, 1979) . It seems that although cellularity does not affect the frequency with which receptor-positive tumours are identified, it does influence the value of REC when present and therefore REc negativity, based on a low receptor value, should be considered with caution in tumours of low cellularity for it may only reflect the lack of epithelial cells (Martin et al., 1979a) . As the presence of RPr is normally closely linked with REC (Martin et al., 1979b ) the dissociation of REC and RPC in relation to cellularity is unexplained.
There is no readily apparent explanation for the observation that receptors occur infrequently in tumours with a prominent lymphocytic infiltration, a relationship which has been reported previously (Rosen et al., 1975) . It seems unlikely that lymphocytes per se are responsible for the absence of receptors within a tumour and this inverse association may merely reflect the observed statistically significant association between heavy lymphoid infiltration and poorly differentiated tumours. A lymphoid reaction is known to be closely related to the degree of malignancy (Fisher et al., 1975) .
The association of hormone receptors with the presence of elastic tissue within the tumour stroma may have a similar explanation for there was a statistical association between histological grade and elastosis, the latter being most marked in welldifferentiated (grade I) tumours. his colleagues (1976, 1978) and Rasmussen et al. (1981) have also found an association between REC and elastosis, a feature which occurs frequently in postmenopausal patients, and an association has been reported between RPC and elastosis (Rolland et al., 1980) . They could give no satisfying explanation for their results. Shivas & Douglas (1972) have shown that patients whose tumours contain elastic tissue survive longer than those who lack it. They are also more likely to respond to endocrine therapy (Masters et al., 1979) . Well-differentiated (grade I) tumours have similar properties (McGuire et al., 1977 clearly associated with a lack of RE, Cooke et al., 1979 Cooke et al., , 1980 Allegra et al., 1979; Hahnel et al., 1979; Forrest et al., 1980; Westerberg et al., 1980) . Patients who have REc are reported to live longer than those who lack it (Bishop et al., 1979; Croton et al., 1981) . Kinne et al. (1981) and Samaan et al. (1981) found no overall difference in the RFS of patients with and without REC but have found small significant differences in subgroups based on node or menopausal status.
The data from the present study, like those of Hilf et al. (1980) Forrest et al. (1980) showed that by merely moving the "cut-off point" separating receptor-rich (+ve) from receptor-poor (low +ve and -ve) tumours, the prognostic value for REC could be eliminated. However, there is good qualitative agreement between centres using the DCC technique, including our own (King et al., 1978) , and the present study has employed similar criteria for receptor positivity to previous reports. Hilf and his colleagues (1980) stressed that clinical factors may cause confusion in interpreting data relating REc status to prognosis, and their observations may also apply to RPc. In early studies numbers were small or receptor data from primary and secondary tumours were combined. In some, no allowance was made for patients receiving additional systemic or local treatment following mastectomy, in others, the status of the axillary nodes was not accurately known, staging being based on pectoral node biopsy, a technique which in our experience may give a false-negative rate of axillary node involvement as high as 20% (Howat & Harris, 1982) .
The length of follow-up is short in many of the reports claiming prolonged RFS (Knight et al., 1977; Pichon et al., 1980) , and actual survival (Bishop et al., 1979; Croton et al., 1981) for receptor +ve patients. Our experience has emphasised the importance of prolonged follow-up. At a median follow-up of 24 months our results were similar to those of Knight et al. (1977) , and Kinne et al. (1981) . We observed an increase in RFS for REc +ve patients with lymph node involvement, but not for any other sub-group. The data suggested that only those with minimal axillary disease (1-3 nodes) benefitted and it was thought that too few node -ve patients had recurred to show any difference attributable to the REC status and that patients with extensive nodal involvement (.4) had recurred too rapidly for any beneficial effect of REC to become apparent.
However, when the median follow-up reached 34 months the difference between REc +ve and RE, -ve patients in the 1-3 node subgroup had disappeared. Hahnel and his colleagues (1979) made similar observations. An apparently advantageous effect of the RE, in node +ve patients seen in the first 2 years after mastectomy disappeared so that at 5 years they too were unable to demonstrate a significant difference between the RFS of REC +ve and -ve patients in any subgroup. Von Maillot et al. (1982) obtained similar results for both REC +ve and RPc +ve patients when they were compared with receptor-negative cases. Benson et al. (1982) made similar observations on survival. At 5 years there was no benefit for RE, +ve patients despite an earlier trend in their favour.
It is not surprising that the progesterone receptor did not influence the RFS in this study for its presence is closely linked to that of REC. Thus one might expect that the absence of any effect on RFS of the REC would be reflected in the results obtained with RPc.
As the data obtained in our study did not demonstrate any marked prognostic value for either REC or RPC status and as the presence of these receptors may merely reflect more easily assessed histological features, we conclude that the measurement of these receptors is of no value in identifying those patients at greatest risk of recurrence. Other factors such as tumour size and axillary node status remain pre-eminent as reliable guides to prognosis.
